Product Information
BETAMETHASONE DP AUG 0.05% GEL is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $2.7396 per GM under NDC 51672130901. Its NADAC has been published 219 times since Nov 28, 2013.
FDA first approved this application on Dec 2, 2003. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Betamethasone Dipropionate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
.5 mg/g
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672130901
Classification
Generic
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
BETAMETHASONE DIPROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA076508FDA Approved
12/2/2003
TE Code
AB
On Market Since
12/2/2003
Pharmacological Classes
Price Statistics
The NADAC for BETAMETHASONE DP AUG 0.05% GEL has been published 219 times since Nov 28, 2013, and over the history we have for it it has declined 2.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7396 per GM |
|---|---|
| All-time high | $3.2969 (Aug 12, 2015) |
| All-time low | $1.7531 (May 22, 2024) |
| 52-week high | $2.7396 |
| 52-week low | $1.8229 |
| Median price | $2.7802 |
| Average price | $2.6376 |
| Largest weekly change | +40.6% (Oct 23, 2024) |
| Weeks tracked | 219 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Betamethasone Dipropionate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Betamethasone Dipropionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BETAMETHASONE DP AUG 0.05% GEL?
The current National Average Drug Acquisition Cost (NADAC) for BETAMETHASONE DP AUG 0.05% GEL, manufactured by Sun Pharmaceutical Industries Inc., is $2.7396 per GM (NDC 51672130901), effective Sep 30, 2026.
How has the price of BETAMETHASONE DP AUG 0.05% GEL changed over time?
Over the history we have for it, the NADAC for BETAMETHASONE DP AUG 0.05% GEL has declined 2.9%. It has been tracked across 219 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BETAMETHASONE DP AUG 0.05% GEL?
Since Nov 28, 2013, the NADAC for BETAMETHASONE DP AUG 0.05% GEL has ranged from a low of $1.7531 (May 22, 2024) to a high of $3.2969 (Aug 12, 2015), with a median of $2.7802 per GM.
Are there cheaper alternatives to BETAMETHASONE DP AUG 0.05% GEL?
No other NADAC-published product currently shares the active ingredient and strength of BETAMETHASONE DP AUG 0.05% GEL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures BETAMETHASONE DP AUG 0.05% GEL?
BETAMETHASONE DP AUG 0.05% GEL (NDC 51672130901) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.